Producing Monoclonal Antibodies For A Tenth Of The Cost
Dutch antibody technology company BiosanaPharma is offering to make monoclonal antibodies at between 5% and 10% the usual cost of manufacture. Video interview from BIO-Europe Spring.
Dutch antibody technology company BiosanaPharma is offering to make monoclonal antibodies at between 5% and 10% the usual cost of manufacture. Video interview from BIO-Europe Spring.